GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Dividend Yield %

HURA (TuHURA Biosciences) Dividend Yield % : 0.00% (As of Mar. 05, 2025)


View and export this data going back to 2024. Start your Free Trial

What is TuHURA Biosciences Dividend Yield %?

As of today (2025-03-05), the Trailing Annual Dividend Yield of TuHURA Biosciences is 0.00%.

The historical rank and industry rank for TuHURA Biosciences's Dividend Yield % or its related term are showing as below:

HURA's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.445
* Ranked among companies with meaningful Dividend Yield % only.

TuHURA Biosciences's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00.

As of today (2025-03-05), the Forward Dividend Yield % of TuHURA Biosciences is 0.00%.

TuHURA Biosciences's Dividends per Share for the three months ended in Sep. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


TuHURA Biosciences Dividend Yield % Historical Data

The historical data trend for TuHURA Biosciences's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences Dividend Yield % Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23
Dividend Yield %
- - -

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24
Dividend Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of TuHURA Biosciences's Dividend Yield %

For the Biotechnology subindustry, TuHURA Biosciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TuHURA Biosciences's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's Dividend Yield % falls into.



TuHURA Biosciences Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


TuHURA Biosciences  (NAS:HURA) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


TuHURA Biosciences Dividend Yield % Related Terms

Thank you for viewing the detailed overview of TuHURA Biosciences's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


TuHURA Biosciences Business Description

Traded in Other Exchanges
N/A
Address
10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.